WPI 2232 (Tamoxifen 10 mg)
Pill imprint WPI 2232 has been identified as Tamoxifen citrate 10 mg.
Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant; breast cancer, palliative; breast cancer, male (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about tamoxifen
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.